Company Filing History:
Years Active: 2025-2026
Title: The Innovative Contributions of Mitchell H. Keylor
Introduction
Mitchell H. Keylor is a notable inventor based in Malden, MA, who has made significant contributions to the field of pharmaceuticals. His work primarily focuses on developing compounds that can aid in the treatment of diseases, particularly those related to LRRK2 kinase.
Latest Patents
Keylor holds a patent for "1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof." This invention is directed towards certain substituted 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives, which are potent inhibitors of LRRK2 kinase. These compounds may be useful in treating or preventing diseases such as Parkinson's Disease, where LRRK2 kinase plays a crucial role.
Career Highlights
Mitchell H. Keylor is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to contribute to the development of innovative pharmaceutical solutions that address critical health issues.
Collaborations
Throughout his career, Keylor has collaborated with esteemed colleagues, including Hua Zhou and John J. Acton, III. These collaborations have enhanced the research and development of effective treatments in the pharmaceutical industry.
Conclusion
Mitchell H